Scarica l'app Stockscreener
102.73
5.96%
-6.51
Pre-mercato:
100.83
-1.90
-1.85%
Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | 0.302 |
Operating Expenses
|
8.37%
27.38
|
25.27 | 54.18 | 17.39 | 96.29 |
| Depreciation and Amortization |
25.00%
0.027
|
0.036 | 0.04 | 0.041 | 0.037 |
| Operating Income/Loss |
8.37%
-27.38
|
-25.27 | -54.18 | -17.39 | -95.98 |
| Income/Loss From Continuing Operations Before Tax |
9.53%
-25.72
|
-23.48 | -52.37 | -15.54 | -94.21 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
9.53%
-25.72
|
-23.48 | -52.37 | -15.54 | -94.21 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | 0.062 | -0.45 | 3.001 |
|
Net Income/Loss
|
9.53%
-25.72
|
-23.48 | -52.31 | -15.98 | -91.21 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.66%
15.55
|
14.18 | 1.1343 | 6.5301 | 4.5638 |
| Diluted Average Shares |
9.66%
15.55
|
14.18 | 1.1343 | 6.5301 | 4.5638 |
| Basic Earnings Per Share |
0.60%
-1.65
|
-1.66 | -4.22 | -2.45 | -19.99 |
| Diluted Earnings Per Share |
0.60%
-1.65
|
-1.66 | -4.22 | -2.45 | -19.99 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):